Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China
· Delayed Price · Currency is CNY 8.67
+0.05 (0.58%)
Apr 30, 2025, 3:04 PM CST
SHE:002873 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 2,005 | 2,190 | 2,868 | 3,339 | 3,224 | 1,869 | Upgrade
|
| Market Cap Growth | -24.69% | -23.62% | -14.13% | 3.58% | 72.48% | -4.04% | Upgrade
|
| Enterprise Value | 2,458 | 2,805 | 3,335 | 3,673 | 3,456 | 2,018 | Upgrade
|
| Last Close Price | 8.67 | 9.43 | 12.30 | 14.20 | 14.05 | 8.02 | Upgrade
|
| PE Ratio | 47.30 | 41.86 | 35.46 | 29.94 | 32.04 | 25.22 | Upgrade
|
| PS Ratio | 2.30 | 2.55 | 3.01 | 3.07 | 3.32 | 2.49 | Upgrade
|
| PB Ratio | 1.67 | 1.83 | 2.58 | 2.98 | 3.62 | 2.26 | Upgrade
|
| P/TBV Ratio | 1.84 | 2.02 | 2.79 | 3.22 | 4.01 | 2.50 | Upgrade
|
| P/FCF Ratio | 82.97 | 82.10 | - | - | 173.24 | 17.37 | Upgrade
|
| P/OCF Ratio | 24.01 | 24.85 | 36.87 | 44.04 | 25.94 | 10.63 | Upgrade
|
| EV/Sales Ratio | 2.81 | 3.27 | 3.50 | 3.38 | 3.56 | 2.69 | Upgrade
|
| EV/EBITDA Ratio | 26.94 | 28.24 | 29.25 | 23.64 | 23.30 | 19.13 | Upgrade
|
| EV/EBIT Ratio | 45.60 | 41.84 | 35.21 | 28.09 | 27.30 | 23.36 | Upgrade
|
| EV/FCF Ratio | 101.72 | 105.13 | - | - | 185.73 | 18.75 | Upgrade
|
| Debt / Equity Ratio | 0.46 | 0.47 | 0.54 | 0.43 | 0.48 | 0.68 | Upgrade
|
| Debt / EBITDA Ratio | 6.06 | 5.54 | 5.14 | 3.11 | 2.88 | 5.35 | Upgrade
|
| Debt / FCF Ratio | 22.89 | 21.00 | - | - | 23.10 | 5.25 | Upgrade
|
| Asset Turnover | 0.46 | 0.44 | 0.51 | 0.65 | 0.63 | 0.57 | Upgrade
|
| Inventory Turnover | 1.51 | 1.38 | 1.19 | 1.64 | 1.96 | 1.83 | Upgrade
|
| Quick Ratio | 1.64 | 0.96 | 0.79 | 0.81 | 1.03 | 1.39 | Upgrade
|
| Current Ratio | 2.16 | 1.28 | 1.15 | 1.22 | 1.33 | 1.58 | Upgrade
|
| Return on Equity (ROE) | 3.70% | 4.53% | 7.24% | 11.08% | 11.71% | 9.64% | Upgrade
|
| Return on Assets (ROA) | 1.76% | 2.17% | 3.16% | 4.86% | 5.17% | 4.12% | Upgrade
|
| Return on Capital (ROIC) | 1.94% | 2.41% | 3.56% | 5.58% | 5.83% | 4.58% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.30% | 4.60% | 7.00% | 9.80% | 11.70% | 8.50% | Upgrade
|
| Earnings Yield | 2.04% | 2.39% | 2.82% | 3.34% | 3.12% | 3.96% | Upgrade
|
| FCF Yield | 1.21% | 1.22% | -0.83% | -1.60% | 0.58% | 5.76% | Upgrade
|
| Dividend Yield | 0.92% | - | 0.57% | 0.70% | 0.61% | 0.76% | Upgrade
|
| Payout Ratio | 108.70% | 67.01% | 52.59% | 30.81% | 30.15% | 35.39% | Upgrade
|
| Buyback Yield / Dilution | 9.10% | 9.91% | -0.41% | 0.41% | -1.34% | -6.59% | Upgrade
|
| Total Shareholder Return | 10.03% | 9.91% | 0.16% | 1.11% | -0.73% | -5.83% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.